Clinical trial
PS-341 Followed by Removal of Prostate for Those With Prostate Cancer
NCT00425503 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00425503 |
|---|---|
| Title | PS-341 Followed by Removal of Prostate for Those With Prostate Cancer |
| Official title | H-11047: A Study of PS-341 Followed by Radical Prostatectomy for Patients With Adenocarcinoma of the Prostate (Spore #: 11-01-30-13) |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Millennium Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Neoplasms |
| Intervention type | Drug |
| Interventions | PS-341 (bortezomib) |
| Enrollment | 40 |
| Start date | Dec 1, 2001 |
| Primary completion | Nov 1, 2012 |
| Completion | Dec 1, 2013 |
| First posted | Jan 23, 2007 |
| Last update posted | Apr 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: